A majority of the studies have reported a heightened adaptive immune response especially in moderate cases of COVID-19, with expanding CD4+ and CD8+ cell populations, in comparison to severe cases, which show T-cell dysregulation and significantly lower levels of CD8+ and CD4+ T cells, B cells, and NK cells (40, 41). This evidence concerns the gene CD8A and COVID-19.